19 related articles for article (PubMed ID: 38215)
1. Ocular metipranolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in glaucoma and ocular hypertension.
Battershill PE; Sorkin EM
Drugs; 1988 Nov; 36(5):601-15. PubMed ID: 2905641
[TBL] [Abstract][Full Text] [Related]
2. Beta-blocking drug metipranolol: plasma levels and pharmacodynamic action in man.
Mayer O; Cepelák V; Vitous J; Potmĕsil J
Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):113-9. PubMed ID: 6103879
[No Abstract] [Full Text] [Related]
3. [The effect of the beta-blockers nadolol and metipranolol in patients with thyrotoxicosis].
Vavrejnová V; Felt V; Nedvídková J
Cas Lek Cesk; 1985 Oct; 124(43):1320-3. PubMed ID: 2867827
[No Abstract] [Full Text] [Related]
4. Plasma catecholamine concentration in hypertensive subjects with chronic renal failure before and during treatment with the beta-receptor blocking drug metipranolol.
Planz G; Haass H; Lamberts B
Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):469-73. PubMed ID: 6128312
[TBL] [Abstract][Full Text] [Related]
5. The effects of metipranolol and other beta-blockers on the heart in reserpinized rats.
Vanĕcek M; Trcka V; Helfert I
Acta Univ Carol Med (Praha); 1980; 26(7-8):339-43. PubMed ID: 6126106
[No Abstract] [Full Text] [Related]
6. [Comparison of the effects of carteolol and metipranolol eyedrops on the ventilatory and cardiovascular functions in asthmatics].
Hugues FC; Le Jeunne C; Munera Y; Dufier JL
J Fr Ophtalmol; 1987; 10(8-9):485-90. PubMed ID: 2892874
[TBL] [Abstract][Full Text] [Related]
7. Effects of beta-blocking agent Metipranolol on metabolic variables in patients with ischemic heart disease, hyperkinetic syndrome, hyperthyreosis and in healthy subjects.
Ceremuzynski L; Zaleska T; Nauman J; Nauman A; Zalewski A
Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):244-9. PubMed ID: 38215
[TBL] [Abstract][Full Text] [Related]
8. [The influence of a beta-adrenolytic premedication on cardiovascular parameters and plasma free fatty acids during esophago-gastro-duodenoscopy (author's transl)].
Pristautz H; Biffl H; Pinl F; Leitner W; Parsché P; Borkenstein J
Wien Med Wochenschr; 1979 Dec; 199(24):707-12. PubMed ID: 44770
[TBL] [Abstract][Full Text] [Related]
9. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
